Skip to content

Innovations in Hearing Accessibility and Technology (IHAT) Study

Effectiveness Trial to Examine the Emerging Service Delivery Models for Over-the-Counter (OTC) Hearing Aids

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06689865
Acronym
IHAT
Enrollment
280
Registered
2024-11-15
Start date
2024-11-13
Completion date
2029-03-31
Last updated
2024-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Aids, Hearing Loss, OTC Hearing Aids

Keywords

hearing loss, hearing aids, OTC hearing aids, service delivery models, effectiveness trial, Over-the-counter hearing aids

Brief summary

The research will explore outcomes of different service delivery models of over-the-counter (OTC) hearing aids by comparing them to prescription hearing aids fitted by specialists in individuals with mild to moderate hearing loss. The investigators will examine how each type affects users' experiences, behavior, thinking skills, and brain activity related to hearing. Additionally, the study will focus on what types of people prefer each hearing aid option, what helps or hinders these choices, and compare the costs of four different service options. This approach will help transition from research findings into real-world practice, providing useful information for healthcare providers and policymakers about OTC hearing aid options.

Detailed description

The aim of the proposed project is to evaluate the effectiveness of emerging over-the-counter (OTC) service delivery models with the gold standard traditional prescription hearing aids fit by hearing care professionals (HCP) using audiology best practices. OTC service delivery models include OTC HA fit to individual users using best practices with in person HCP support (OTC-HPC), via remote consultation (OTC-R) and self-fit OTC HAs without any clinical support (OTC-SF). The study will use a prospective four-arm randomized controlled trial design with longitudinal repeated measures.

Interventions

DEVICEHA-HCP

Prescription hearing aid fit by a hearing healthcare professional using audiology best practices.

DEVICEOTC-HCP

Over-the-counter hearing aids fit by a hearing care professional using audiology best practices.

DEVICEOTC-R

OTC fit to an individual using some best practices via remote consultation.

DEVICEOTC-SF

Self-fit OTC hearing aids without any clinical support from HCPs.

Sponsors

National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult onset, bilateral, mild-to-moderate sensorineural hearing loss documented by audiological evaluation * Aged 40 years or older * No previous HA experience greater than 3 months * Able to read and understand patient education materials * Willing to be randomized to one of the four groups, and * Owns a smartphone

Exclusion criteria

* Hearing loss that is too severe for OTC HAs * Middle ear disorders or conductive pathology present * Asymmetrical hearing loss * Diagnosed neurological condition such as dementia or Parkinson's disease or a score lower than 25 on the MOCA * Non-English speaking as it may impact the ability to complete our test battery

Design outcomes

Primary

MeasureTime frameDescription
Abbreviated Profile of Hearing Aid Benefit (APHAB)T0 = Baseline, T1 = 6 months post intervention, T2 = 12 months post interventionIt is a 24-item self-reported measure of hearing disability and hearing aid benefit. It includes four subscales that address different listening challenges: ease of communication, reverberation, background noise, and aversiveness of sounds, with each subscales comprising six items. The ease of communication, reverberation, and background noise primarily measure challenges related to speech communication. The global score on the APHAB is the average of these three subscale scores. The hearing aid benefit is calculated by comparing the difficulty level reported without amplification (unaided) to the difficulty level with amplification (aided). Scores range from 1% to 99%, with higher scores indicating greater perceived hearing difficulty.

Secondary

MeasureTime frameDescription
Satisfaction with Amplification in Daily Living (SADL)T0= Baseline, T1= 6 months post intervention, T2= 12 months post interventionSADL is a 15-item self-reported outcome measure that evaluates an individual's satisfaction with their hearing aids on a 7-point rating scale. The questionnaire is divided into four subscales. The positive effect subscale quantifies improved performance with hearing aids. The personal image subscale quantifies self-image and stigma. The negative feature subscale evaluates undesirable aspects of using hearing aids. The service and cost subscale assesses the adequacy of the professional's service and the device's cost. Higher scores indicate greater satisfaction with hearing aids.
Revised Hearing Handicap Inventory -Screening (RHHI-S)T0= Baseline, T1= 6 months post intervention, T2= 12 months post interventionIt is a 10-item self-perceived hearing handicap measure that can be used for adults of all ages. The response options on this scale are yes (4), sometimes (2), and no (0), and ranges from 0 to 40. The total score is the sum of all the responses, with higher scales indicating greater perceived difficulties.
Patient Global Impression of Change (PGI-C)T1= 6 months post intervention, T2= 12 months post interventionPGI-C assesses the patient's belief about the efficacy of treatment with a single-item questionnaire on a 7-point rating scale. Lower scores indicate improved outcomes.
Connected Speech Test (CST)T0= Baseline, T1= 6 months post intervention, T2= 12 months post interventionThe connected speech test is a sentence intelligibility test consisting of 48 passages with 8-10 sentences of a connected discourse spoken by a female speaker. A pair of passages will be presented to the participant, and the 25 keywords in each passage will be scored for percentage correct score. A higher percentage correct score indicates higher sentence intelligibility.
Quick Speech in Noise (QuickSIN)T0= Baseline, T1= 6 months post intervention, T2= 12 months post interventionIt assesses the patient's ability to hear in background noise. The patient repeats sentences that are embedded in different noisy environments and the result is a signal-to-noise ratio loss. The test stimuli are pre-recorded sentences embedded in speech babble at varying signal-to-noise ratios from easy to very difficult.

Countries

United States

Contacts

Primary ContactResearch Service Professional
ihat@cuanschutz.edu303-724-8465
Backup ContactPreeti Pandey, PhD
preeti.pandey@cuanschutz.edu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026